HIV Clinical Trial
Official title:
Community-based Combination HIV Prevention in Tanzanian Women at Heightened Risk
The Phase II trial will assess the feasibility, acceptance, safety, pathways, and initial effectiveness of a community-based combination HIV prevention intervention among bar-based female sex workers in Iringa, Tanzania. Results will inform an appropriately powered Phase III RCT as warranted.
Combination HIV prevention demonstrates significant promise in reducing burden of disease. To
maximize its effectiveness combination prevention must be tailored to a given context and
population. From the beginning of the global HIV epidemic, female sex workers (FSWs) have
been found to be at heightened risk for infection. More recently the role that sex work plays
in ongoing HIV transmission dynamics has been more clearly established in generalized
epidemics, where previously limited attention was paid to the role of key populations. The
greater vulnerability of FSWs is now widely understood to be associated with social and
structural factors including the intense stigma, discrimination and violence they often face
and the unsafe environments in which they live and work. These factors are known to limit
both protective sexual behaviors and engagement in HIV testing, care and treatment services.
Comprehensive, community-based HIV prevention approaches addressing the aforementioned social
and structural vulnerabilities to HIV infection among FSWs have been shown to be effective in
South Asia and in Latin America. However, in sub-Saharan Africa where the impact of HIV is
the greatest, no systematic efforts to develop and evaluate the feasibility and effectiveness
of community-based combination HIV prevention among FSWs has occurred.
The investigators will conduct a two-arm Phase II community randomized controlled trial of a
community-based combination HIV prevention intervention among FSWs in Iringa, Tanzania. The
model was developed on the basis of prior formative research and mapping and utilizes an
ongoing research infrastructure. The combination package will include integrated biomedical,
behavioral and structural components: (1) mobile HIV testing and risk reduction counseling;
(2) service navigation to facilitate access to treatment and retention in care; (3)
sensitivity training for HIV clinical care providers; (4) SMS text messages to promote
adherence to care and ART; (5) venue-based peer education and condom distribution; and (6) a
community drop-in-center to promote cohesion and collective action to reduce stigma and
discrimination. The investigators seek to establish base rates of key outcomes including HIV
incidence and viral load suppression, examine the socio-structural and behavioral pathways of
the intervention, assess feasibility, acceptability and safety, and document preliminary
effectiveness. Should compelling indications of safety, feasibility, acceptability and
initial effectiveness be found, study results will inform the first Phase III RCT of
community-based combination HIV prevention among FSWs.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06162897 -
Case Management Dyad
|
N/A | |
| Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
| Completed |
NCT02528773 -
Efficacy of ART to Interrupt HIV Transmission Networks
|
||
| Active, not recruiting |
NCT05454839 -
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
|
||
| Recruiting |
NCT05322629 -
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
|
N/A | |
| Completed |
NCT02579135 -
Reducing HIV Risk Among Adolescents: Evaluating Project HEART
|
N/A | |
| Active, not recruiting |
NCT01790373 -
Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
|
N/A | |
| Not yet recruiting |
NCT06044792 -
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
|
||
| Completed |
NCT04039217 -
Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
|
Phase 4 | |
| Active, not recruiting |
NCT04519970 -
Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)
|
N/A | |
| Completed |
NCT04124536 -
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
|
N/A | |
| Recruiting |
NCT05599581 -
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
|
N/A | |
| Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
| Completed |
NCT02758093 -
Speed of Processing Training in Adults With HIV
|
N/A | |
| Completed |
NCT02500446 -
Dolutegravir Impact on Residual Replication
|
Phase 4 | |
| Completed |
NCT03805451 -
Life Steps for PrEP for Youth
|
N/A | |
| Active, not recruiting |
NCT03902431 -
Translating the ABCS Into HIV Care
|
N/A | |
| Completed |
NCT00729391 -
Women-Focused HIV Prevention in the Western Cape
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
| Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 |